Multicentre Selective Lymphadenectomy Trial 1: key primary data remain unavailable.

Autor: Dixon A; Australasian College of Cutaneous Oncology, Melbourne, VIC, Australia., Kyrgidis A; Aristotle University of Thessaloniki, Thessaloniki, Greece., Zachary C; University of California, Irvine, CA, USA., Dixon J; Swinburne University of Technology, Melbourne, VIC, Australia., Popescu C; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania., Sladden M; University of Tasmania, Launceston, TAS, Australia., Apalla Z; Aristotle University of Thessaloniki, Thessaloniki, Greece., Anderson S; Maffra Medical Group, Maffra, VIC, Australia., Argenziano G; University of Campania, Campania, Italy., Ioannides D; Aristotle University of Thessaloniki, Thessaloniki, Greece., Nirenberg A; Australasian College of Cutaneous Oncology, Melbourne, VIC, Australia., Lallas A; Aristotle University of Thessaloniki, Thessaloniki, Greece., Zagarella S; University of Sydney, Sydney, NSW, Australia., Longo C; University of Modena and Reggio Emilia, Modena, Italy., Smith H; Oxford Dermatology, Perth, WA, Australia., Steinman H; Campbell University, Buies Creek, NC, USA., Tzellos T; Arctic University of Norway, Tromsø, Norway., Cleaver L; A T Still University, Kirksville, MO, USA., Leahey K; Harbour Medical Services, Adelaide, SA, Australia., Zouboulis CC; Brandenburg Medical School, Theodor Fontane and Faculty of Health Sciences, Brandenburg, Dessau, Germany., Thomas JM; Royal Marsden Hospital, Chelsea, London, UK.
Jazyk: angličtina
Zdroj: The British journal of dermatology [Br J Dermatol] 2022 Dec; Vol. 187 (6), pp. 997-998. Date of Electronic Publication: 2022 Jul 12.
DOI: 10.1111/bjd.21712
Databáze: MEDLINE